James Barlow
Vermögen: 67 200 $ am 30.06.2026
Vermögen: 67 200 $ am 30.06.2026
James F.
Barlow is currently Director at Arcturus Therapeutics, Inc., Independent Director at Arcturus Therapeutics Ltd. since 2018, Independent Director at Arcturus Therapeutics Holdings, Inc. since 2018, Director at Nahs Holding, Inc. since 2018, and Vice President at Vicept Therapeutics, Inc. Former roles include Chief Accounting Officer, Senior VP & Controller at Allergan, Inc. from 2002 to 2015, Treasurer & Controller at Wynn's International, Inc. from 1990 to 2000, Vice President & Controller at Ford Equipment Leasing Co. from 1986 to 1990, Principal at Deloitte Haskins & Sells (US) in 1985, and Chief Financial Officer at Winco Enterprises, Inc. in 2001.
Education includes undergraduate and graduate degrees from Brigham Young University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 10.000 ( 0,04 % ) | 67 200 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Direktor/Vorstandsmitglied | 27.05.2018 |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops dermatologic therapeutic products | Corporate Officer/Principal | - |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direktor/Vorstandsmitglied | 27.05.2018 |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direktor/Vorstandsmitglied | - |
Nahs Holding, Inc. | Direktor/Vorstandsmitglied | 01.07.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
| ALLERGAN, INC. | Comptroller/Controller/Auditor | 01.03.2015 |
Winco Enterprises, Inc.
Winco Enterprises, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures and markets automotive & industrial chemical products | Finanzdirektor/CFO | 01.08.2001 |
Wynn's International, Inc.
Wynn's International, Inc. Automotive AftermarketConsumer Durables Supplies automotive, industrial components and specialty chemical products | Comptroller/Controller/Auditor | 01.09.2000 |
Ford Equipment Leasing Co. | Comptroller/Controller/Auditor | 01.01.1990 |
| ░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Wynn's International, Inc.
Wynn's International, Inc. Automotive AftermarketConsumer Durables Supplies automotive, industrial components and specialty chemical products | Consumer Durables |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops dermatologic therapeutic products | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Winco Enterprises, Inc.
Winco Enterprises, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures and markets automotive & industrial chemical products | Process Industries |
Ford Equipment Leasing Co. | |
Deloitte Haskins & Sells (US) | |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Nahs Holding, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen